| 
|  | Pimobendan(Vetmedin)Description of:Pimobendan (Vetmedin)Pimobendan (Vetmedin) is a calcium sensitizer with positive inotropic and vasodilator effects. It is als...
 More>> |  | 
| 
|  | PF-2545920Description of:PF-2545920PF-2545920 a highly selective and potent PDE10A inhibitor with an IC50 of 0.37 nM.
 Theoretical analysi...
 More>> |  | 
| 
|  | GSK256066Description of:GSK256066GSK256066 is an exceptionally high affinity and selective inhibitor of PDE4 that inhibits PDE4 isoforms A-D with equ...
 More>> |  | 
| 
|  | Cilomilast(SB-207499)Description of:Cilomilast(SB-207499)Cilomilast (SB-207499) inhibits HPDE4 and LPDE4 catalytic activity with equal potency (Ki ≈100 nM). ...
 More>> |  | 
| 
|  | TH-302Description of:TH-302TH-302 is a selectively targeting hypoxic regions of solid tumors hypoxia-activated prodrug. 
Theoretical analysis:T...
 More>> |  | 
| 
|  | TAK-700 (Orteronel)Description of:TAK-700 (Orteronel)orteronel(TAK-700) is currently in phase III clinical trials for the treatment of castration-resistant prost...
 More>> |  | 
| 
|  | Avasimibe(CI-1011)Description of:Avasimibe(CI-1011)Avasimibe (CI-1011) is an orally bioavailable Acyl-CoA:Cholesterol O-Acyltransferase (ACAT) inhibitor.
T...
 More>> |  | 
| 
|  | ApixabanDescription of:ApixabanApixaban is a compound being investigated as an anticoagulant. Apixaban has similar affinity for human and rabbit facto...
 More>> |  | 
| 
|  | Rivaroxaban(Xarelto)Description of:Rivaroxaban(Xarelto)Rivaroxaban significantly reduced the primary efficacy end point, as compared with placebo, with respective...
 More>> |  |